Veri Medtech files for initial public offering with SEC

Veri Medtech Holdings Inc. (OTC: VRHI) filed a registration statement on Form S-1 with the Securities and Exchange Commission for a proposed initial public offering of its Class A common stock, the company announced.

The healthcare technology company has not determined the number of shares to be offered or the price range for the proposed offering. The offering remains subject to market conditions, and there is no assurance regarding whether or when it may be completed or the actual size and terms.

The registration statement has been filed but has not yet become effective. Securities may not be sold, nor may offers to buy be accepted, prior to the registration statement becoming effective, according to the filing.

Veri Medtech operates as a healthcare technology platform offering alternative medicine, personalized diagnostics, and wellness medication services. The company uses telehealth infrastructure and digital systems to provide healthcare services.

The company owns subsidiaries Veriheal, which focuses on alternative medicine treatments, and DosePop, which provides mental and physical health services including weight loss and anti-aging treatments.

You May Also Be Interested In

• Forbright completes $142.2 million IPO on Nasdaq
• Crinetics presents CAH trial data for atumelnant at ENDO 2026
• Parabilis Medicines closes $770.5 million IPO and concurrent private placement